This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Download the interactive ‘KEYTRUDA® (pembrolizumab) in HNSCC and treatment modifications for associated immune-related adverse events’ guide

Prescribing Information

Click the button above to access a downloadable interactive PDF document ‘An overview of KEYTRUDA® in HNSCC and treatment modifications for associated immune-related adverse events’.

More information about KEYTRUDA® (pembrolizumab):

Supporting documentation

GB-OHN-00147 | Date of Preparation: July 2020